journal article·2023-09Open access

Smoke and Spike: Benzo[a]pyrene Enhances SARS‐CoV‐2 Infection by Boosting NR4A2‐Induced ACE2 and TMPRSS2 Expression

Wenbin Liu, Yue Zhao, Junyan Fan, Jiaying Shen, Hailin Tang, Wanda Tang, Di Wu, Weijin Huang, Yibo Ding, Peng Qiao, Jiansheng Lin, Zishuai Li, Qianqian Li, Qianqian Cui, Yan Liu, Yifan Chen, Rui Pu, Xue Han, Jianhua Yin, Xiaojie Tan, Guangwen Cao

Advanced Science· Volume 10· Issue 26

Abstract

Abstract Cigarette smoke aggravates severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection. However, the underlying mechanisms remain unclear. Here, they show that benzo[a]pyrene in cigarette smoke extract facilitates SARS‐CoV‐2 infection via upregulating angiotensin‐converting enzyme 2 (ACE2) and transmembrane protease serine 2 (TMPRSS2). Benzo[a]pyrene trans‐activates the promoters of ACE2 and TMPRSS2 by upregulating nuclear receptor subfamily 4 A number 2 (NR4A2) and promoting its binding of NR4A2 to their promoters, which is independent of functional genetic polymorphisms in ACE2 and TMPRSS2. Benzo[a]pyrene increases the susceptibility of lung epithelial cells to SARS‐CoV‐2 pseudoviruses and facilitates the infection of authentic Omicron BA.5 in primary human alveolar type II cells, lung organoids, and lung and testis of hamsters. Increased expression of Nr4a2, Ace2, and Tmprss2, as well as decreased methylation of CpG islands at the Nr4a2 promoter are observed in aged mice compared to their younger counterparts. NR4A2 knockdown or interferon‐λ2/λ3 stimulation downregulates the expression of NR4A2, ACE2, and TMPRSS2, thereby inhibiting the infection. In conclusion, benzo[a]pyrene enhances SARS‐CoV‐2 infection by boosting NR4A2‐induced ACE2 and TMPRSS2 expression. This study elucidates the mechanisms underlying the detrimental effects of cigarette smoking on SARS‐CoV‐2 infection and provides prophylactic options for coronavirus disease 2019, particularly for the elderly population.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Nuclear Receptors and Signaling · RNA Interference and Gene Delivery · MicroRNA in disease regulation

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Key Laboratory of Biosafety Defense Ministry of Education Shanghai 200433 China

Shanghai Key Laboratory of Medical Biodefense Shanghai 200433 China

Department of Epidemiology Second Military Medical University Shanghai 200433 China

Shanghai East Hospital Key Laboratory of Arrhythmias Ministry of Education Tongji University School of Medicine Tongji University Shanghai 200331 China

Department of Microbiology Second Military Medical University Shanghai 200433 China

Seven Plus Technology Company Limited Tianjin 300301 China

Institute for Biological Product Control National Institutes for Food and Drug Control WHO Collaborating Center for Standardization and Evaluation of Biologicals NHC Key Laboratory of Research on Quality and Standardization of Biotech Products and NMPA Key Laboratory for Quality Research and Evaluation of Biological Products Beijing 102629 China

Department of Infectious Disease Control Center for Disease Control and Prevention of Yangpu District Shanghai 200090 China

Department of Epidemiology School of Medicine Jinan University Guangzhou China

Funding

National Key Research and Development Program of China · National Natural Science Foundation of China

References (63)

Show source-provided references
1. WHO.2022. “Coronavirus disease (COVID‐19) pandemic.” World Health Organization https://www.who.int/emergencies/diseases/novel‐coronavirus‐2019(accessed: December 2022).
2. 10.1016/j.cell.2022.09.01810.1016/j.cell.2022.09.018 ↗
3. 10.1016/j.cell.2022.06.00510.1016/j.cell.2022.06.005 ↗
4. 10.1038/s41586-020-2012-710.1038/s41586-020-2012-7 ↗
5. 10.1038/s41586-022-04464-z10.1038/s41586-022-04464-z ↗
6. 10.1002/EXP.2021008210.1002/EXP.20210082 ↗
7. 10.1002/EXP.2021023210.1002/EXP.20210232 ↗
8. 10.1007/s12274-022-4627-510.1007/s12274-022-4627-5 ↗
9. 10.1016/j.cell.2020.04.03510.1016/j.cell.2020.04.035 ↗
10. 10.1128/jvi.01140-2210.1128/jvi.01140-22 ↗
11. 10.1038/s41586-022-04462-110.1038/s41586-022-04462-1 ↗
12. 10.1016/j.ebiom.2022.10427010.1016/j.ebiom.2022.104270 ↗
13. 10.1002/jcp.3005410.1002/jcp.30054 ↗
14. 10.1093/cid/ciaa85110.1093/cid/ciaa851 ↗
15. 10.7150/thno.4807610.7150/thno.48076 ↗
16. 10.1136/thoraxjnl-2021-21708010.1136/thoraxjnl-2021-217080 ↗
17. 10.1111/joim.1319010.1111/joim.13190 ↗
18. 10.1016/S2213-2600(22)00182-510.1016/S2213-2600(22)00182-5 ↗
19. 10.1016/j.devcel.2020.05.01210.1016/j.devcel.2020.05.012 ↗
20. 10.1002/path.555510.1002/path.5555 ↗
21. 10.3390/ijms2214766910.3390/ijms22147669 ↗
22. 10.5334/aogh.367010.5334/aogh.3670 ↗
23. 10.1016/j.onehlt.2020.10017410.1016/j.onehlt.2020.100174 ↗
24. 10.1186/s40249-020-00780-610.1186/s40249-020-00780-6 ↗
25. 10.1056/NEJMsa201168610.1056/NEJMsa2011686 ↗
26. 10.1093/cid/ciac85010.1093/cid/ciac850 ↗
27. 10.3390/ijerph1909547910.3390/ijerph19095479 ↗
28. 10.2471/BLT.22.28821110.2471/BLT.22.288211 ↗
29. 10.3390/ijms2115551310.3390/ijms21155513 ↗
30. 10.3390/ijms2311634810.3390/ijms23116348 ↗
31. 10.1002/jat.396910.1002/jat.3969 ↗
32. 10.1007/s10661-022-10297-010.1007/s10661-022-10297-0 ↗
33. 10.5334/aogh.390710.5334/aogh.3907 ↗
34. 10.1016/j.envpol.2022.11946910.1016/j.envpol.2022.119469 ↗
35. 10.3389/fimmu.2022.86633910.3389/fimmu.2022.866339 ↗
36. 10.1002/advs.20210464010.1002/advs.202104640 ↗
37. 10.1002/cncr.2822810.1002/cncr.28228 ↗
38. 10.1016/j.ejca.2013.06.00110.1016/j.ejca.2013.06.001 ↗
39. 10.1165/rcmb.2004-0389OC10.1165/rcmb.2004-0389OC ↗
40. Hussain S. P. · Cancer Res. · 2001 · 61 · 6350
41. 10.1038/srep2510810.1038/srep25108 ↗
42. 10.1186/1476-4598-9-9310.1186/1476-4598-9-93 ↗
43. 10.1038/s41586-020-2818-310.1038/s41586-020-2818-3 ↗
44. 10.1186/s12916-020-01673-z10.1186/s12916-020-01673-z ↗
45. 10.1016/j.bbrc.2020.05.17910.1016/j.bbrc.2020.05.179 ↗
46. 10.1158/0008-5472.CAN-17-310210.1158/0008-5472.CAN-17-3102 ↗
47. 10.21037/tlcr.2017.07.0210.21037/tlcr.2017.07.02 ↗
48. 10.1016/j.chom.2021.05.00410.1016/j.chom.2021.05.004 ↗
49. 10.1007/s00432-022-04253-110.1007/s00432-022-04253-1 ↗
50. 10.1007/s11684-021-0837-610.1007/s11684-021-0837-6 ↗
51. 10.1073/pnas.220237011910.1073/pnas.2202370119 ↗
52. 10.1128/jvi.00364-2210.1128/jvi.00364-22 ↗
53. 10.1016/j.celrep.2022.11079910.1016/j.celrep.2022.110799 ↗
54. 10.1084/jem.2022062110.1084/jem.20220621 ↗
55. 10.1016/j.stemcr.2021.02.00510.1016/j.stemcr.2021.02.005 ↗
56. 10.1073/pnas.040142210110.1073/pnas.0401422101 ↗
57. 10.1080/22221751.2020.174376710.1080/22221751.2020.1743767 ↗
58. 10.1016/j.cell.2021.02.04210.1016/j.cell.2021.02.042 ↗
59. 10.1038/s41596-020-0394-510.1038/s41596-020-0394-5 ↗
60. Peng H. R. · Acad. J. Second Mil. Med. Univ. · 2020 · 41 · 365
61. 10.1186/1471-2164-9-17810.1186/1471-2164-9-178 ↗
62. 10.1126/scitranslmed.300025110.1126/scitranslmed.3000251 ↗
63. 10.1371/journal.pone.000165110.1371/journal.pone.0001651 ↗